References
- Kasahara K, Inoue K, Shuin T. Advanced adenocarcinoma of the urinary bladder successfully treated by the combination of cisplatinum, mitomycin-C, etoposide and tegafur-uracil chemotherapy. Int J Urol 2001; 8: 133–6
- Abe H, Nishimura T, Ito H, Oka F, Ikeda K. Bladder-preserving treatment for vesical transitional cell carcinoma associated with adenocarcinoma and squamous cell carcinoma. Nishinihon J Urol 1998; 60: 334–6
- Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder and related urinary structures. Atlas of tumor pathology, J Rosai, LH Sobin. Armed Forces Institute of Pathology, Washington, D. C. 1994; 254–5
- Kunze E, Francksen B. Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study. Urol Res 2002; 30: 66–78
- Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992; 51: 1229–39
- Niho S, Yokose T, Kodama T, Nishiwaki Y, Mukai K. Clonal analysis of adenosquamous carcinoma of the lung. Jpn J Cancer Res 1999; 90: 1244–7
- Ohguchi N, Sakaida N, Okamura A, Kawakita S, Kawamura H, Matsuda T. Extravesical tumor implantation caused by perforation during transurethral resection of a bladder tumor. Int J Urol 1997; 4: 516–8